MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with U

Ursodeoxycholic acid

Ursodeoxycholic acid 150mg tablets

Compatible

Stability notes for Ursodeoxycholic acid 150mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Destolit 150mg tablets (Norgine Pharmaceuticals Ltd).

Suppliers (6) of Ursodeoxycholic acid 150mg tablets
Ursodeoxycholic acid 150mg tablets (A A H Pharmaceuticals Ltd)
Ursodeoxycholic acid 150mg tablets (Alliance Healthcare (Distribution) Ltd)
Ursodeoxycholic acid 150mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Ursodeoxycholic acid 150mg tablets (Medihealth (Northern) Ltd)
Ursodeoxycholic acid 150mg tablets (Necessity Supplies Ltd)
Ursodeoxycholic acid 150mg tablets (Teva UK Ltd)

Ursodeoxycholic acid 250mg capsules

Compatible

Stability notes for Ursodeoxycholic acid 250mg capsules

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Ursofalk 250mg capsules (Dr. Falk Pharma UK Ltd).

Suppliers (12) of Ursodeoxycholic acid 250mg capsules
Ursodeoxycholic acid 250mg capsules (A A H Pharmaceuticals Ltd)
Ursodeoxycholic acid 250mg capsules (Advanz Pharma)
Ursodeoxycholic acid 250mg capsules (Alissa Healthcare Research Ltd)
Ursodeoxycholic acid 250mg capsules (Alliance Healthcare (Distribution) Ltd)
Ursodeoxycholic acid 250mg capsules (Glenmark Pharmaceuticals Europe Ltd)
Ursodeoxycholic acid 250mg capsules (Grindeks Kalceks UK Ltd)
Ursodeoxycholic acid 250mg capsules (Medihealth (Northern) Ltd)
Ursodeoxycholic acid 250mg capsules (Strides Pharma UK Ltd)
Ursofalk 250mg capsules (Dr. Falk Pharma UK Ltd)
Ursofalk 250mg capsules (Lexon (UK) Ltd)
Ursofalk 250mg capsules (Sigma Pharmaceuticals Plc)
Ursonorm 250mg capsules (PRO.MED.CS Praha a.s.)

Ursodeoxycholic acid 250mg tablets

No stability information

Stability notes for Ursodeoxycholic acid 250mg tablets

There are no stability notes for this medicine.

Supplier

Cholurso 250mg tablets (Mayoly UK Ltd)

Ursodeoxycholic acid 300mg tablets

No stability information

Stability notes for Ursodeoxycholic acid 300mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Ursodeoxycholic acid 300mg tablets
Ursodeoxycholic acid 300mg tablets (A A H Pharmaceuticals Ltd)
Ursodeoxycholic acid 300mg tablets (Alliance Healthcare (Distribution) Ltd)
Ursodeoxycholic acid 300mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Ursodeoxycholic acid 300mg tablets (Medihealth (Northern) Ltd)
Ursodeoxycholic acid 300mg tablets (Necessity Supplies Ltd)
Ursodeoxycholic acid 300mg tablets (Wockhardt UK Ltd)

Ursodeoxycholic acid 400mg tablets

No stability information

Stability notes for Ursodeoxycholic acid 400mg tablets

There are no stability notes for this medicine.

Supplier

Ursonorm 400mg tablets (PRO.MED.CS Praha a.s.)

Ursodeoxycholic acid 500mg capsules

No stability information

Stability notes for Ursodeoxycholic acid 500mg capsules

There are no stability notes for this medicine.

Suppliers

Ursodeoxycholic acid 500mg capsules (A A H Pharmaceuticals Ltd)
Ursodeoxycholic acid 500mg capsules (Alissa Healthcare Research Ltd)
Ursodeoxycholic acid 500mg capsules (Alliance Healthcare (Distribution) Ltd)

Ursodeoxycholic acid 500mg tablets

No stability information

Stability notes for Ursodeoxycholic acid 500mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Ursodeoxycholic acid 500mg tablets
Cholurso 500mg tablets (Mayoly UK Ltd)
Ursofalk 500mg tablets (CST Pharma Ltd)
Ursofalk 500mg tablets (Dr. Falk Pharma UK Ltd)
Ursofalk 500mg tablets (Necessity Supplies Ltd)
Ursofalk 500mg tablets (Pilsco Ltd)
Ursonorm 500mg tablets (PRO.MED.CS Praha a.s.)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.